SE7714782L - Nya dehydrooligopeptider till anvendning som lekemedel och sett att framstella foreningarna - Google Patents

Nya dehydrooligopeptider till anvendning som lekemedel och sett att framstella foreningarna

Info

Publication number
SE7714782L
SE7714782L SE7714782A SE7714782A SE7714782L SE 7714782 L SE7714782 L SE 7714782L SE 7714782 A SE7714782 A SE 7714782A SE 7714782 A SE7714782 A SE 7714782A SE 7714782 L SE7714782 L SE 7714782L
Authority
SE
Sweden
Prior art keywords
dehydrooligopeptids
associations
medicines
produce
new
Prior art date
Application number
SE7714782A
Other languages
English (en)
Inventor
E Etschenberg
W Opitz
S Raddatz
Original Assignee
Troponwerke Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19762659114 external-priority patent/DE2659114A1/de
Priority claimed from DE19772745584 external-priority patent/DE2745584A1/de
Application filed by Troponwerke Gmbh & Co Kg filed Critical Troponwerke Gmbh & Co Kg
Publication of SE7714782L publication Critical patent/SE7714782L/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0812Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
SE7714782A 1976-12-28 1977-12-27 Nya dehydrooligopeptider till anvendning som lekemedel och sett att framstella foreningarna SE7714782L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19762659114 DE2659114A1 (de) 1976-12-28 1976-12-28 Neue dehydrooligopeptide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE19772745584 DE2745584A1 (de) 1977-10-11 1977-10-11 Neue dehydrooligopeptide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
SE7714782L true SE7714782L (sv) 1978-06-29

Family

ID=25771313

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7714782A SE7714782L (sv) 1976-12-28 1977-12-27 Nya dehydrooligopeptider till anvendning som lekemedel och sett att framstella foreningarna

Country Status (12)

Country Link
US (1) US4276288A (sv)
JP (1) JPS5382721A (sv)
AT (1) AT360185B (sv)
AU (1) AU509040B2 (sv)
DK (1) DK581577A (sv)
ES (1) ES465518A1 (sv)
FI (1) FI773922A (sv)
FR (1) FR2376128A1 (sv)
GB (1) GB1568137A (sv)
NL (1) NL7714440A (sv)
NO (1) NO774303L (sv)
SE (1) SE7714782L (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1141374A (en) * 1978-07-03 1983-02-15 Charles H. Stammer Preparation of dehydropeptides
DE2904512A1 (de) * 1979-02-07 1980-08-28 Troponwerke Gmbh & Co Kg Dehydropeptide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4610816A (en) * 1980-12-18 1986-09-09 Schering Corporation Substituted dipeptides as inhibitors of enkephalinases
US4906615A (en) * 1980-12-18 1990-03-06 Schering Corporation Substituted dipeptides as inhibitors of enkephalinases
US4465668A (en) * 1981-02-27 1984-08-14 Asahi Kasei Kogyo Kabushiki Kaisha Method for improving intestinal absorption of cephalosporin derivatives
CS277405B6 (en) * 1986-06-12 1993-03-17 Vyzk Ustav Farm Biochem Sp Peptides with 1-amino-1-cycloalkane carboxylic acid
US4970297A (en) * 1987-03-13 1990-11-13 Syntex (U.S.A.) Inc. Transglutaminase inhibitors
US4996348A (en) * 1987-07-29 1991-02-26 Ciba-Geigy Corporation N-alkenoyl enamides, their preparation and the use thereof

Also Published As

Publication number Publication date
JPS5382721A (en) 1978-07-21
GB1568137A (en) 1980-05-29
FR2376128A1 (fr) 1978-07-28
AU3191377A (en) 1979-06-28
FI773922A (fi) 1978-06-29
FR2376128B1 (sv) 1980-06-13
NL7714440A (nl) 1978-06-30
DK581577A (da) 1978-06-29
ATA932677A (de) 1980-05-15
AU509040B2 (en) 1980-04-17
ES465518A1 (es) 1979-05-01
US4276288A (en) 1981-06-30
NO774303L (no) 1978-06-29
AT360185B (de) 1980-12-29

Similar Documents

Publication Publication Date Title
SE7504409L (sv) Sett att framstella nya pyridinderivat och anvendning derav som lekemedel.
SE7602317L (sv) 1,4-dihydropyridinkarbonsyraalkylestrar till anvendning som lekemedel och sett att framstella desamma
SE407014B (sv) Kirurgisk anordning och sett att tillverka densamma
SE7808804L (sv) Nya 5-hydroximetyl-2-ixazolidinoner, sett att framstella desamma och deras terapeutiska anvendning
SE7602339L (sv) Kinolonderivat och sett att framstella desamma
SE7605925L (sv) Nya prostanderivat och sett att framstella desamma
SE7808184L (sv) Nya prostaglandin-iŸ2-derivat och sett att framstella desamma
SE435928B (sv) Sett att framstella nya 3-aryl-oxazolidin-2-oner
SE7805269L (sv) Azolyleterderivat till anvendning som fungicider och sett att framstella foreningarna
SE7601197L (sv) Nya orala rontgenkontrastmedel och sett att framstella desamma
SE7708621L (sv) 2-bensyl-pyrrolidiner, sett for framstellning derav och anvendning derav som lekemedel
SE7714782L (sv) Nya dehydrooligopeptider till anvendning som lekemedel och sett att framstella foreningarna
SE7602707L (sv) Karbonsyraamider, sett att framstella dessa och deras anvendning som lekemedel
FI773812A (fi) Farmaceutiska foereningar
SE7604083L (sv) Nya 11-oxo-prostaglandinderivat och sett att framstella desamma
SE7711038L (sv) Nya kortikoider och sett att framstella desamma
SE7614107L (sv) Depa-steroidestrar och sett att framstella desamma
SE7703948L (sv) Nya anibakteriella foreningar
SE7601927L (sv) Nya isocyanater och sett att framstella dessa
SE7608887L (sv) Foreningar av cefalosporin-typ och sett att framstella desamma
SE7508543L (sv) Nya oxifenylbutazon-derivat och sett att framstella desamma.
SE7711821L (sv) N-kloracetyl-n-fenyl-alaninestrar till anvendning som fungicider och sett att framstella foreningarna
SE7607148L (sv) Nya xantensyraderivat och sett att framstella desamma
SE7505711L (sv) Nya tiofenderivat och sett att framstella desamma
SE7605357L (sv) Sett att framstella nya cefemforeningar